Research article · 20 Apr 2017
Conference abstractPublished 12 Sep 2016
Regulatory network analysis reveals miR-146b-5p within BCR-ABL1–positive microvesicles promotes leukemic transformation of hematopoietic cells
Huazhong University of Science and Technology, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Evidence is accumulating that extracellular microvesicles (MV) facilitate progression and relapse in cancer. Using a model in which MVs derived from K562 chronic myelogenous leukemia (CML) cells transform normal hematopoietic transplants into leukemia-like cells, we defined the underlying mechanisms of this process through gene-expression studies and network analyses of transcription factors (TF) and miRNAs. We found that antitumor miRNAs were increased and several defense pathways were initiated during the early phases of oncogenic transformation. Later, oncomiRs and genes involved in cell cycle, DNA repair and energy metabolism pathways were upregulated. Regulatory network analyses revealed that a number of TFs and miRNAs were responsible for the pathway dysregulation and the oncogenic transformation. In particular, we found that miR-146b-5p, which was highly expressed in MVs, coordinated the regulation of cancer-related genes to promote cell-transforming processes. Notably, treatment of recipient cells with MV derived from K562 cells expressing mimics of miR-146b-5p revealed that it accelerated the transformation process in large part by silencing the tumor-suppressor NUMB. High levels of miR-146b-5p also enhanced reactive oxygen species levels and genome instability of recipient cells. Taken together, our findings showed how upregulation of oncogenic miRNAs in MVs promote hematopoetic cells to a leukemic state, as well as a demonstration for TF and miRNA coregulatory analysis in exploring the dysregulation of cancers and discovering key factors.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2017
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML)
Case report · 2014
Detection of Jak2 V617f Mutation, Secondary to the Presence of Bcr-Abl1 Translocation in a Patient with Chronic Myeloid Leukemia: Report of a Case and Review of the Literature
Conference abstract · 2022
Hsa-miR-181a-5p, hsa-miR-182-5p and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
Commentary · 18 Mar 2024
Allogeneic Stem Cell Transplantation for BCR-ABL1 Fusion-Positive Acute Myeloid Leukemia
More from this journal
The newest in Transcriptomics: Open Access.
Commentary · 30 Dec 2025
Transcriptomic Biomarkers for Early Diagnosis and Prognosis of Diseases
Commentary · 30 Dec 2025
Metatranscriptomics for Understanding Microbial Community Functionality
Commentary · 30 Dec 2025
Single-Nucleus Transcriptomics in Neurological Disorder Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranscriptomics: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “An Yuan Guo”
- BylineArticles whose byline prints “Hong Mei Zhang”
- BylineArticles whose byline prints “Qing Li”
- BylineArticles whose byline prints “Xiaojian Zhu”

